Clinical Trials Logo
  1. Home
  2. Hepatitis E
  3. NCT03168412

A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)

Hepatitis E Clinical Trial

Official title:
A Study on Immunogenicity of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® Using Accelerated Vaccination Schedule in Adults (Aged Over 18 Years)

Clinical Trial Summary

This phase IV clinical study was designed to evaluate the immunogenicity and safety of the recombinant Hepatitis E vaccine (Hecolin®), manufactured by Xiamen Innovax Biotech CO., LTD., in healthy adults (over 18 years) with accelerated vaccination schedule. The study volunteers will receive the 3 doses of Hecolin® administered intramuscularly according to a 0-7-21 days schedule or a 0-1-6 month schedule.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03168412
Study type Interventional
Source Xiamen Innovax Biotech Co., Ltd
Contact
Status Completed
Phase Phase 4
Start date May 25, 2017
Completion date November 28, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT03365921 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) Phase 4
Completed NCT02584543 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) Phase 4
Not yet recruiting NCT03488589 - HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
Completed NCT03601221 - Seroprevalence Hepatitis E Infection in Healthy Blood Donors
Completed NCT02189603 - Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®） Phase 4
Completed NCT02847507 - Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
Completed NCT02603055 - A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults Phase 1
Completed NCT02190253 - Seroprevalence of Hepatitis E in People With an Organ Transplant
Recruiting NCT06457438 - Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors N/A
Completed NCT04670419 - Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
Completed NCT03282474 - HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) Phase 2
Terminated NCT02558114 - Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection. Phase 4
Recruiting NCT06137313 - Exposure to Hepatitis E Virus in Occitania, France
Completed NCT02964910 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) Phase 4
Completed NCT01014845 - Clinical Trial of Recombinant Hepatitis E Vaccine Phase 3
Recruiting NCT05976594 - Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
Completed NCT02417597 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli) Phase 4
Completed NCT03827395 - Safety Study of Hepatitis E Vaccine (HEV239) Phase 1